Cardiovascular co-morbidity in rheumatic diseases

C Turesson, LTH Jacobsson… - Vascular health and risk …, 2008 - Taylor & Francis
Patients with rheumatic disorders have an increased risk of cardiovascular disease (CVD).
This excess co-morbidity is not fully explained by traditional risk factors. Disease severity is a …

Osteoarthritis of the peripheral joints

IF Petersson, LTH Jacobsson - Best practice & research Clinical …, 2002 - Elsevier
Osteoarthritis (OA) is a complex process affecting many different joint areas in the body.
From a pathophysiological point of view some features are crucial for the diagnosis, such as …

Swedish registers to examine drug safety and clinical issues in RA

…, CM Fored, P Geborek, LTH Jacobsson… - Annals of the …, 2006 - ard.bmj.com
Data from several different monitoring systems are examined. The potential for registers
based on data obtained from clinical practice, and linkage of such data to national health and …

Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?

DR McCance, DJ Pettitt, RL Hanson, LTH Jacobsson… - Bmj, 1994 - bmj.com
Objective : To determine the prevalence of diabetes in relation to birth weight in Pima Indians.
Design : Follow up study of infants born during 1940-72 who had undergone a glucose …

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

LTH Jacobsson, C Turesson, A Gülfe… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) in patients with rheumatoid
arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors, compared to a standard …

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

DR McCane, RL Hanson, MA Charles, LTH Jacobsson… - Bmj, 1994 - bmj.com
Objective : To compare the ability of tests measuring two hour plasma glucose, fasting
plasma glucose, and glycated haemoglobin concentrations in predicting the specific …

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors

…, T Mandl, R Manthorpe, LTH Jacobsson - Annals of the …, 2006 - ard.bmj.com
Objectives: To assess the risk of lymphoproliferative disease or other malignancy (standardised
incidence ratios (SIRs)), in patients with primary Sjögren’s syndrome according to the …

Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study

…, R Manthorpe, LTH Jacobsson - Arthritis & Rheumatism …, 2004 - Wiley Online Library
Objective. This study was undertaken to analyze standardized mortality ratios (SMRs) and
causes and predictors of death in primary Sjögren’s syndrome (SS) diagnosed according to 3 …

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

AJ Mohammad, LTH Jacobsson, KWA Westman… - …, 2009 - academic.oup.com
Objective. To estimate the incidence of and survival rates for WG, microscopic polyangiitis (MPA),
Churg–Strauss syndrome (CSS) and PAN within a defined population in southern …

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

LTH Jacobsson, C Turesson, JÅ Nilsson… - Annals of the …, 2007 - ard.bmj.com
Objective: To assess mortality in patients with rheumatoid arthritis (RA) treated with tumour
necrosis factor (TNF) inhibitors, compared with a standard RA population. Methods: Patients …